Pharmacokinetics and mammary elimination of imidocarb in sheep and goats

Journal of Dairy Science

Volumn 89, Issue 7, 2006, Pages 2465-2472

  Belloli, C ^a   Lai, O R ^a   Ormas, P ^a   Zizzadoro, C ^a   Sasso, G ^a   Crescenzo, G ^a  

^a UNIVERSITY OF BARI   (Italy)

Author keywords

Imidocarb; Milk residues; Pharmacokinetics; Small ruminant

Indexed keywords

ACARI; ANIMALIA; BABESIA; BOVIDAE; CAPRA HIRCUS; OVIS; OVIS ARIES;

EID: 33745902824     PISSN: 00220302     EISSN: None     Source Type: Journal    
DOI: 10.3168/jds.S0022-0302(06)72320-7     Document Type: Article

References (27)

1. Aliu, Y. O., R. H. Davis, B. J. Camp, and K. L. Kuttler. 1977. Absorption, distribution and excretion of imidocarb dipropionate in sheep. Am. J. Vet. Res. 38:2001-2007.
2. Baggot, J. D. 2001. Interpretation of changes in drug disposition and interspecies scaling. Pages 92-135 in The Physiological Basis of Veterinary Clinical Pharmacology. J. D. Baggot, ed. Blackwell Science Ltd., Oxford, UK.
3. Belloli, C., G. Crescenzo, O. R. Lai, V. Carofiglio, O. Marangi, and P. Ormas. 2002. Pharmacokinetics of imidocarb dipropionate in horse after intramuscular administration. Equine Vet. J. 34:625-629.
4. Bergonier, D., R. de Crémoux, R. Rupp, G. Lagriffoul, and X. Berthelot. 2003. Mastitis of dairy small ruminants. Vet. Res. 34:689-716.
5. Brasseur, P., S. Lecoublet, N. Kapel, L. Favennec, and J. J. Ballet. 1998. In vitro evaluation of drug susceptibility of Babesia divergens isolated. Antimicrob. Agents Chemother. 42:818-820.
6. Coldham, N. G., A. S. Moore, M. Dave, P. J. Graham, S. Sivapathasundaram, B. G. Lake, and M. J. Sauer. 1995. Imidocarb residues in edible bovine tissues and in vitro assessment of imidocarb metabolism and cytotoxicity. Drug Metab. Dispos. 23:501-505.
7. Crescenzo, G., O. R. Lai, C. Belloli, G. Sasso, and P. Ormas. 2002. Validated analytical methods for determination of imidocarb in tissues and milk of cattle, sheep and goats. Ital. J. Food Sci. 14:99-111.
8. CVMP. 2003. Imidocarb (Extension to sheep). Summary report. EMEA/MRL/881/03-FINAL (www.emea.eu.int). Committee for Medicinal Products for Veterinary Use, European Medicines Agency, London, UK.
9. CVMP. 1998. Guideline on validation of analytical procedures: Methodology. EMEA/CVMP/VICH/591/98-FINAL (www.emea.eu.int). Committee for Medicinal Products for Veterinary Use, European Medicines Agency, London, UK.
10. CVMP. 1997. Note for guidance on establishment of maximum residue limits for minor animal species. EMEA/CVMP/153a/97-FINAL (www.emea.eu.int). Committee for Medicinal Products for Veterinary Use, European Medicines Agency, London, UK.
11. Gummow, B., J. L. Du Preez, and G. E. Swan. 1995. Paired-ion extraction and high-performance liquid Chromatographic determination of diminazene in cattle plasma: A modified method. Onderstepoort J. Vet. 62:1-5.
12. Kaneko, J. J., J. W. Harvey, and M. L. Bruss. 2002. Appendixes VIII. Pages 893-894 in Clinical Biochemistry of Domestic Animals. 5th ed. J. J. Kaneko, J. W. Harvey, and M. L. Bruss, ed. Academic Press, London, UK.
13. Knowles, R. C., J. L. Hurrigan, and A. A. Holbrook. 1980. Equine piroplasmosis. Equine Pract. 2:10-14.
14. Kuttler, K. L. 1980. Pharmacotherapeutics of drugs used in treatment of anaplasmosis and babesiosis. J. Am. Vet. Med. Assoc. 176:1103-1108.
15. Lai, O. R., C. Belloli, G. Crescenzo, V. Carofiglio, O. Marangi, P. Cagnardi, and P. Ormas. 2002. Depletion and bioavailability of imidocarb residues in sheep and goat tissues. Vet. Hum. Toxicol. 44:79-83.
16. Lam, F. C., C. T. Humg, and D. G. Perrier. 1985. Estimation of variance for harmonic mean half-lives. J. Pharmacol. Sci. 74:229-231.
17. McHardy, N. 1983. The prophylactic activity of imidocarb against tick-transmitted parasitic infections. Pages 247-254 in Veterinary Pharmacology and Toxicology. Y. Ruckebusch, P. L. Toutain and G. D Koritz, ed. MRP Press Ltd., Lancaster, UK.
18. Moore, A. S., N. G. Coldham, and M. J. Sauer. 1996. A cellular mechanism for imidocarb retention in edible bovine tissues. Toxicol. Lett. 87:61-68.
19. Nari, A. 1995. Strategies for the control of one-host ticks and relationship with tick-borne diseases in South America. Vet. Parasitol. 57:153-165.
20. Riegelman, S., and P. Collier. 1980. The application of the statistical moment theory to the evaluation of in vivo dissolution time and absorption time. J. Pharmacokinet. Biopharm. 8:509-534.
21. Rodriguez, R. I., and A. J. Trees. 1996. In vitro responsiveness of Babesia bovis to imidocarb dipropionate and selection of drug-adapted-line. Vet. Parasitol. 62:35-41.
22. Taha, A. A., H. A. Elsheikh, A. E. Khalafalla, I. A. Osman, and A. S. Abdullah. 1999. Disposition kinetics of tylosin administered intravenously and intramuscularly in Desert sheep and Nubian goats. Vet. J. 158:210-215.
23. Tarbin, J. A., and G. Shearer. 1992. High-performance liquid chromatographic determination of imidocarb in cattle kidney with cation-exchange clean-up. J. Chromatogr. B. 577:376-381.
24. Uilenberg, G. 1995. International collaborative research: Significance of tick-borne hemoparasitic disease to world animal health. Vet. Parasitol. 57:19-41.
25. World Health Organization (WHO). 2003. Evaluation of certain veterinary drug residues in food. Pages 16-19 in 60th report of the Joint FAO/WHO Expert Committee on Food Additives. Technical Report Series, WHO 918. WHO, Geneva, Switzerland.
26. World Health Organization (WHO). 1999. Evaluation of certain veterinary drug residues in food. Pages 56-66 in 50th report of the Joint FAO/WHO Expert Committee on Food Additives. Technical Report Series, WHO 888. WHO, Geneva, Switzerland.
27. Yamaoka, K., Y. Tanigawara, T. Nakagawa, and T. Uno. 1978. Application of Akaike's information criterion (AIC) in the evaluation of linear pharmacokinetic equations. J. Pharmacokinet. Biopharm. 6:165-175.